Across TCGA pan-cancer cohorts, STIM1-AS1 RNA is linked to patient survival in 25 of 34 cancer types, making it the most broadly survival-associated STIM1-AS1 data layer.
The strongest signal is observed in mesothelioma (MESO), where higher STIM1-AS1 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated STIM1-AS1 expression acts as an unfavorable survival marker, although some lineages such as MESO and ESCA show a favorable association.
MESO, KIRC, and BLCA are the cancer types where STIM1-AS1 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.